B

Blueprint Medicines Corp

D

BPMC

USD

1.79

(1.7956%)

Market Closed

18,330.00

Volume

-4.55

EPS

-

Div Yield

-29.759531

P/E

6,428,297,788.20

Market Cap

Today

1.7956%

1 Week

16.123%

1 Month

13.652%

6 Months

-6.685%

12 Months

67.431%

Year To Date

9.934%

All Time

0%

Related Instruments

Title:
Blueprint Medicines Corp

Sector:

Healthcare

Industry:

Biotechnology

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

Do you need help or have a question?